Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

PROCEPT BioRobotics (PRCT) Cost of Revenue (2020 - 2026)

PROCEPT BioRobotics has reported Cost of Revenue over the past 7 years, most recently at $29.2 million for Q1 2026.

  • Quarterly Cost of Revenue rose 16.74% to $29.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $116.0 million through Mar 2026, up 24.89% year-over-year, with the annual reading at $111.8 million for FY2025, 27.95% up from the prior year.
  • Cost of Revenue was $29.2 million for Q1 2026 at PROCEPT BioRobotics, down from $30.1 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $30.1 million in Q4 2025 and troughed at $6.5 million in Q1 2022.
  • The 5-year median for Cost of Revenue is $21.5 million (2024), against an average of $19.5 million.
  • Year-over-year, Cost of Revenue surged 133.03% in 2022 and then grew 10.02% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $13.1 million in 2022, then skyrocketed by 70.41% to $22.3 million in 2023, then rose by 10.02% to $24.6 million in 2024, then increased by 22.41% to $30.1 million in 2025, then dropped by 2.94% to $29.2 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Cost of Revenue are $29.2 million (Q1 2026), $30.1 million (Q4 2025), and $29.3 million (Q3 2025).